Ezivac%2525252525252525252525252525252520enema

# Ezivac enema ## Overview Ezivac (Sodium Citrate / Sodium Lauryl Sulfoacetate / Sorbitol) is a hypertonic micro-enema used for rapid rectal evacuation of the bowel. It acts as a saline laxative by increasing osmotic pressure in the colon, softening the stool and promoting peristalsis through local irritation. ## Primary Indications * Relief of constipation. * Bowel preparation for proctoscopic or sigmoidoscopic examinations. ## Adult Dosing * One micro-enema (5 mL) administered rectally as a single dose. * If symptoms persist, a second dose may be administered, but chronic use is discouraged. ## Pediatric Dosing * **Children > 3 years:** One micro-enema (5 mL) rectally. * **Children < 3 years:** One micro-enema (5 mL) rectally; however, clinical discretion is required. * *Note: Always verify specific pediatric institutional protocols, as some facilities limit use in infants.* ## Dose Adjustments * **Renal Impairment:** Use with caution in patients with renal failure due to the risk of hypernatremia or electrolyte imbalances. * **Hepatic Impairment:** No specific adjustment required, but use caution in patients with ascites or fluid overload. ## Contraindications * Known hypersensitivity to any component (sodium citrate, sodium lauryl sulfoacetate, sorbitol). * Abdominal pain of unknown origin. * Nausea, vomiting, or suspected bowel obstruction. * Hemorrhoids or anal fissures (may cause stinging or irritation). * Presence of inflammatory bowel disease (ulcerative colitis, Crohn’s disease). ## Adverse Effects * **Common:** Anal irritation, burning, or stinging sensation during administration. * **Rare:** Rectal bleeding or ulceration (usually due to improper insertion technique), abdominal cramps, diarrhea. * **Systemic:** Potential for electrolyte imbalance if used excessively. ## Key Drug Interactions * Minimal systemic absorption; therefore, clinically significant drug-drug interactions are unlikely. * Avoid concomitant use with other rectal preparations (e.g., mesalamine) to prevent potential dilution or irritation. ## Monitoring * Frequency of bowel movements. * Signs of anal mucosa damage or inflammation. * Electrolytes (only if used repeatedly or in high-risk populations). ## Clinical Pearls * **Administration:** Ensure the patient is in the left lateral position. Advance the applicator tip carefully to avoid mucosal injury. Contents should be squeezed fully, then withdrawn while keeping the tube compressed to prevent backflow. * **Onset:** Typically effective within 5 to 20 minutes. * **Usage:** This product is intended for short-term symptomatic relief only. Chronic constipation warrants investigation into dietary, hydration, or lifestyle factors. * **Lubrication:** The neck of the applicator is usually pre-lubricated; if not, apply a small amount of water-soluble lubricant to the tip. *** **Educational Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Consult the manufacturer’s package insert, your institutional formulary, or local clinical protocols before prescribing or administering any medication. Clinical judgment should always override general guidelines.